Collapse versus aggregation of proteins

蛋白质的塌陷与聚集

基本信息

项目摘要

In this award from the Chemistry of Life Processes Program in the Chemistry Division, Dr. B. Montgomery Pettitt, from the University of Texas Medical Branch, Galveston, seeks to understand, through computational approaches, the role of the solubility of the backbone and side chains in folding and recognition in peptides and proteins.The mechanisms governing recognition between proteins and the transition of proteins from their unfolded state to their native state in cells still remain as elusive fundamental questions. Recent experiments studying the interactions between cellular osmolytes and proteins have challenged the prevailing paradigm of the protein folding mechanism. Interpretation of those experiments holds that the backbone solubility difference in osmolyte is a dominant driving force rather than just the sidechains. Recent theoretical efforts to date have not resolved the issue. Dr. Pettitt's goals are to computationally test hypotheses concerning the magnitude of the nonideal backbone solubility in comparison to side chain solvation as driving forces in protein folding. His group will use glycine oligomers as models for the protein backbone and alanine oligomers as small fast folders to understand side chain effects in quantitative comparison to backbone.This research effort aims to resolve a critical issue concerning the chemical driving force for all protein folding. This goal has many far reaching societal benefits and is generally important for the fields of protein engineering and biotechnology. As such it will provide numerous interdisciplinary opportunities for the inclusion of women and underrepresented groups in the project. All participants will be encouraged to attend both national and local meetings of relevance. Dr. Pettitt is well positioned to recruit minority and female students and post-doctorates to participate in this project. His group works with the Rice/Houston Alliance for Graduate Education and the Professoriate and the Houston-Louis Stokes Alliance for Minority Participation, which includes the University of Houston-Downtown, Texas State University-San Marcos, and Texas Southern University, among others.
来自加尔维斯顿德克萨斯大学医学分校的B.Montgomery Pettit博士在化学部生命过程化学项目的这一奖项中,试图通过计算方法了解主链和侧链的溶解性在多肽和蛋白质折叠和识别中的作用。控制蛋白质之间识别的机制以及蛋白质在细胞中从未折叠状态到自然状态的转变仍然是难以捉摸的基本问题。最近研究细胞渗透分子和蛋白质相互作用的实验对蛋白质折叠机制的主流范式提出了挑战。对这些实验的解释认为,骨架在渗透沸石中的溶解度差异是主导驱动力,而不仅仅是侧链。到目前为止,最近的理论努力还没有解决这个问题。派提特博士的目标是通过计算测试与侧链溶剂化作为蛋白质折叠驱动力的非理想主链溶解度的大小相关的假设。他的团队将使用甘氨酸低聚物作为蛋白质骨架的模型,使用丙氨酸低聚物作为小的快速文件夹,以了解与骨架的定量比较中的侧链效应。这项研究旨在解决关于所有蛋白质折叠的化学驱动力的关键问题。这一目标具有许多深远的社会效益,通常对蛋白质工程和生物技术领域很重要。因此,它将为将妇女和代表性不足的群体纳入该项目提供许多跨学科的机会。将鼓励所有与会者参加有意义的国家和地方会议。佩蒂特博士很有能力招募少数族裔和女性学生以及博士后参与这一项目。他的团队与莱斯/休斯顿研究生教育和教授联盟以及休斯顿-路易斯·斯托克斯少数群体参与联盟合作,该联盟包括休斯顿市中心大学、德克萨斯州立大学圣马科斯分校和德克萨斯南方大学等。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

B. Montgomery Pettitt其他文献

Size dependence of thermodynamic and kinetic stability in liquid-liquid phase-separated clusters: Insights from a simple computational model
  • DOI:
    10.1016/j.bpj.2023.11.2974
  • 发表时间:
    2024-02-08
  • 期刊:
  • 影响因子:
  • 作者:
    Caleb Huang;B. Montgomery Pettitt
  • 通讯作者:
    B. Montgomery Pettitt
Effect of cyclization on the liquid-liquid phase separation of pentaglycine
  • DOI:
    10.1016/j.bpj.2021.11.1993
  • 发表时间:
    2022-02-11
  • 期刊:
  • 影响因子:
  • 作者:
    Riley J. Workman;B. Montgomery Pettitt
  • 通讯作者:
    B. Montgomery Pettitt
Reconstruction of solvent structure: contribution of higher-order proximal distribution functions
  • DOI:
    10.1016/j.bpj.2021.11.2778
  • 发表时间:
    2022-02-11
  • 期刊:
  • 影响因子:
  • 作者:
    Razie Yousefi;Gillian C. Lynch;Madeline Galbraith;B. Montgomery Pettitt
  • 通讯作者:
    B. Montgomery Pettitt
DNA Shape Shifting as a Gene Therapy Tool
  • DOI:
    10.1016/j.bpj.2018.11.948
  • 发表时间:
    2019-02-15
  • 期刊:
  • 影响因子:
  • 作者:
    Jonathan M. Fogg;Qian Wang;Allison Judge;Erik Stricker;B. Montgomery Pettitt;Lynn Zechiedrich
  • 通讯作者:
    Lynn Zechiedrich
Free Energy Landscape of Nonspecific Protein-DNA Encounter
  • DOI:
    10.1016/j.bpj.2009.12.424
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Chuanying Chen;B. Montgomery Pettitt
  • 通讯作者:
    B. Montgomery Pettitt

B. Montgomery Pettitt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('B. Montgomery Pettitt', 18)}}的其他基金

Rapid Solvation Thermodynamics Calculations for Proteins
蛋白质的快速溶剂化热力学计算
  • 批准号:
    1709310
  • 财政年份:
    2017
  • 资助金额:
    $ 39万
  • 项目类别:
    Continuing Grant
Replacement of the Chemistry Computer System
更换化学计算机系统
  • 批准号:
    9214348
  • 财政年份:
    1992
  • 资助金额:
    $ 39万
  • 项目类别:
    Standard Grant

相似国自然基金

Jagged2high CD11bhigh 调节性树突状细胞防治cGVHD的实验研究
  • 批准号:
    30972790
  • 批准年份:
    2009
  • 资助金额:
    28.0 万元
  • 项目类别:
    面上项目
MSC介导的抑止性T细胞级联在allo-BMT后GVHD中的作用与机制研究
  • 批准号:
    30801051
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Hematopoietic Stem Cell Transplantation Combined with CSF1 Inhibition to Attenuate the Pathogenesis of Alzheimer's Disease
造血干细胞移植联合CSF1抑制可减轻阿尔茨海默病的发病机制
  • 批准号:
    10318999
  • 财政年份:
    2021
  • 资助金额:
    $ 39万
  • 项目类别:
Safe and effective anti CD154 antibodies for therapeutic intervention
用于治疗干预的安全有效的抗 CD154 抗体
  • 批准号:
    8523637
  • 财政年份:
    2012
  • 资助金额:
    $ 39万
  • 项目类别:
Safe and effective anti CD154 antibodies for therapeutic intervention
用于治疗干预的安全有效的抗 CD154 抗体
  • 批准号:
    8609546
  • 财政年份:
    2012
  • 资助金额:
    $ 39万
  • 项目类别:
BMT Clinical Trial Network at Stanford
斯坦福大学 BMT 临床试验网络
  • 批准号:
    9973202
  • 财政年份:
    2001
  • 资助金额:
    $ 39万
  • 项目类别:
BMT Clinical Trial Network at Stanford
斯坦福大学 BMT 临床试验网络
  • 批准号:
    10187627
  • 财政年份:
    2001
  • 资助金额:
    $ 39万
  • 项目类别:
BMT Clinical Trial Network at Stanford
斯坦福大学 BMT 临床试验网络
  • 批准号:
    10458475
  • 财政年份:
    2001
  • 资助金额:
    $ 39万
  • 项目类别:
BMT Clinical Trial Network at Stanford
斯坦福大学 BMT 临床试验网络
  • 批准号:
    10657438
  • 财政年份:
    2001
  • 资助金额:
    $ 39万
  • 项目类别:
BMT Clinical Trial Network at Stanford
斯坦福大学 BMT 临床试验网络
  • 批准号:
    9385589
  • 财政年份:
    2001
  • 资助金额:
    $ 39万
  • 项目类别:
CLOPIDOGREL VERSUS ASPIRIN IN PATIENTS AT RISK OF ISCHEMIC EVENTS
氯吡格雷与阿司匹林治疗有缺血事件风险的患者
  • 批准号:
    6245978
  • 财政年份:
    1997
  • 资助金额:
    $ 39万
  • 项目类别:
DOPAMINERGIC NEURONS: CELL INTERACTIONS AND PLASTICITY
多巴胺能神经元:细胞相互作用和可塑性
  • 批准号:
    3399804
  • 财政年份:
    1983
  • 资助金额:
    $ 39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了